Join our Facebook group
👉 Remote Jobs NetworkDynavax is a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines to help protect the world against infectious diseases$1. .$1
Infectious Diseases, Biodefense, Vaccine Manufacturing and Vaccines
201 - 500
💰 $200M Post-IPO Debt on 2021-05
July 24
201 - 500
Lead process development for Dynavax’s drug product portfolio in vaccine manufacturing.
July 24
201 - 500
Lead marketing strategies for HEPLISAV-B, a hepatitis B vaccine, in the US market.